Plain-English translation of NCT06899399 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a minimally invasive procedure called endovascular stenting—combined with heart-protective medications—can better prevent strokes than medication alone in people who have a significantly narrowed carotid artery in their neck but haven't had a stroke yet. The carotid arteries are major blood vessels that supply blood to your brain, and when they become severely narrow, there's a risk of stroke even without obvious symptoms. Researchers want to know if placing a small metal stent to open up the artery reduces that risk.
Many people discover they have a severely narrowed carotid artery by chance on imaging scans, with no warning signs. It's unclear whether the invasive procedure of stent placement is worth the risks compared to simply treating with medications and lifestyle changes, so this trial aims to settle that question.
You likely qualify if…
You likely don't qualify if…
If you qualify, you'll be randomly assigned to one of two groups: one group receives the stent procedure plus heart-protective medications, and the other receives medication management alone. Both groups will take medications to manage blood pressure, cholesterol, and prevent blood clots. You'll visit the hospital or clinic for baseline testing, the procedure (if assigned to the stent group), and follow-up visits at 30 days, 6 months, and 12 months to check for any complications and monitor your brain health with cognitive tests.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China